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Abstract 
 
The metallic radioisotope of a known radiopharmaceutical chelate, 67Ga(NOTA) 
(NOTA=1,4,7-triazacyclonane-1,4,7-triacetic acid), used for tumor detection, was 
substituted by the chemically similar but non radioactive aluminum ion. Our aim was to 
detect and evaluate the in vivo behavior of the chelate. For this purpose, Al(NOTA) and 
the related chelate Al(NODASA) (NODASA=1,4,7-triazacyclononane-1-succinic acid-
4,7-diacetic acid) were studied using in vitro and in vivo 27Al NMR spectroscopy in 
rats. Both chelates showed high stability towards acid catalyzed dissociation and their 
27Al NMR resonances are characteristic of highly symmetrical species, with chemical 
shifts within the range for octahedral or pseudo-octahedral geometries.  The 
thermodynamic stability constant of the novel chelate Al(NODASA) was estimated 
using 27Al NMR. The obtained value suggested that the chelate does not undergo in 
vivo demetalation by transferrin.  The in vivo spectroscopic studies and the analysis of 
blood and urine samples for Al(III) concentrations indicated that the chelates remain 
intact under physiological conditions and that they are mainly eliminated from the body 
through the kidneys. 
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1. Introduction 
 
Metal chelates find wide applications both as diagnostic and therapeutic agents 
in biomedical sciences.  Gadolinium chelates are being used as paramagnetic contrast 
agents for MRI [1-3].  Radiochelates of gamma or positron emitting metals find strong 
application in Nuclear Medicine, e.g, chelates of gallium-67/68, indium-111 or copper-
64 in tumor detection, and chelates of yttrium-90 and rhenium-188 in internal tumor 
therapy [4, 5]. 
Radiochelates of Ga(III) are often used in scintigraphy for diagnostic procedures 
[6, 7].  The radioactive 67Ga(NOTA) (NOTA=1,4,7-triazacyclonane-1,4,7-triacetic 
acid) is an interesting radiopharmaceutical agent [8].  Parker et al substituted the 
radioactive gallium in Ga(NOTA) by the NMR sensitive cold gallium (69/71Ga) and 
performed an in vivo 71Ga NMR study [9].  Recently Geraldes et al studied other 
gallium chelates of triazacyclononane ligands also using 71Ga NMR spectroscopy [10].  
We previously performed an in vivo 69Ga NMR study with Ga(NODASA) 
(NODASA=1,4,7- triazacyclononane-1-succinic acid-4,7-diacetic acid) [11]. 
The main goal of this work was to detect and evaluate the in vivo behavior of 
Ga(NOTA)- like metal chelates.  For this purpose we used Al(NOTA) (Figure1–a) and 
the closely related Al(NODASA) (Figure1-b) as models. These chelates were 
investigated by in vitro and in vivo 27Al NMR spectroscopy in rats. 
The non radioactive Al(III) ion, being magnetically active, has an NMR signal 
which may give information about the chemical structure and integrity of its chelates 
under in vivo conditions.   
The quadrupole splitting of the Al(III) ion is small in a highly symmetrical 
environment but can be as large as several MHz in an asymmetrical one.  Large 
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quadrupole splitting will broaden the resonance beyond detection; consequently, the 
observation of high resolution NMR will be limited to complexes in which the nucleus 
experiences a highly symmetrical environment [12]. 
27Al has a 1.5 times higher NMR sensitivity than 71Ga and its natural abundance 
is 100 % compared to 40 % of 71Ga resulting in a 3.7 fold increase in absolute sensitivity 
[12].  Simple calculation using the spin numbers and the quadrupole moments of 27Al 
and 71Ga shows that for isostructural chelates the ratio of the linewidths of 27Al and71Ga 
resonances is about 0.4.  Consequently, the observation of 27Al resonances may be 
easier. 
Aluminum possesses an NMR sensitivity of 21 % relative to the proton and its 
short T1- relaxation time allows fast data sampling.  In a previous work with aluminum 
containing drugs Seelig et al demonstrated that the Al- nucleus is suitable for MRI [13].  
NOTA, with its three carboxylates and the three nitrogen atoms in the 
cyclononane moiety, is a suitable chelator to form a highly symmetrical octahedral 
Al(III) complex affording a narrow 27Al NMR signal. In spite of its narrow signal the 
sensitivity is low due to the low solubility of Al(NOTA) in water at room temperature.  
For this reason we aimed at the synthesis of a new ligand based on NOTA but with an 
extra carboxylic acid group (NODASA).  Solutions of Al(NOTA) and Al(NODASA) 
were intravenously administrated to rats and the aluminum signals of the chelates were 
observed by in vivo 27Al NMR spectroscopy.  
 
2. Experimental 
2.1 - Synthesis 
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NOTA. This ligand was synthesized according to a procedure published 
elsewhere [14,15].  Crystals of Al(NOTA) were prepared also according to a method 
described in the literature [16]. 
NODASA. This ligand was prepared according to our method previously 
published [11].  Crystals of Al(NODASA) were prepared using 0.130 g of NODASA 
(2.88x10-4 mol) and 0.106 g of Al(NO3)3.9H2O (2.88x10-4 mol) which were dissolved in 
4 mL of water.  The pH was adjusted to 3-4 with the addition of 1 M NaOH(aq) and the 
solution was heated at 70 oC during 1 hour.  The small amount of white precipitate 
formed was filtrated off and by slow evaporation of water small crystals were obtained 
which were recrystallized from water. 
1H NMR (400 MHz, D2O, pD=4.4): δ 2.65-3.05 (overlapping m’s, –CHCH2COOH, 2H 
and ethylenic ring protons, 2H); 3.05-3.15 (m, ethylenic ring protons, 2H); 3.15-3.25 
(m, ethylenic ring protons, 4H); 3.35-3.45 (m, ethylenic ring protons, 2H); 3.45-3.55 
(m, ethylenic ring protons, 2H); 3.75 (m, –CH2COO-, 4H); 4.10 (m, –CHCH2COOH, 
1H). 
13C NMR (90 MHz, D2O, pD=4.4): δ 32.0 (C12); 45.0 (C2, 9); 52.0 (C3, 5, 6, 8); 62.5 
(C10, 10’); 66 (C11); 175 (carboxylates). 
m/z (ESI-): 384.0 (M-H-, 100) 
IR (cm-1): 1303 (COO- sy); 1665 (COO- as); 1715 (COOH) 
 
2.2 - Preparation of solutions  
Al(NOTA) and Al(NODASA) solutions for in vitro 27Al NMR experiments 
were prepared by dissolving the respective crystals in the appropriate volume of water 
for a final  concentration of 10 mM. 
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The chelate solutions for in vivo studies were prepared by dissolving the 
respective crystals in NaCl isotonic solution in order to obtain saturated solutions at 
room temperature (20.75 mg of Al(NOTA)/5 mL and 40.30 mg of Al(NODASA)/5 
mL). 
2.3 - Stability of the Chelates 
For the estimation of the thermodynamic stability constant of Al(NODASA) we 
used a batch method consisting of several samples which contained a fixed 
concentration of Al(III) of 19.8 mM (Al(NO3)3.9H2O was used). The ligand 
concentration was different from sample to sample (the ratio [NODASA]/[Al(III)]  was 
varied from 0.10 to 2.0).  The samples were made up to a volume of 0.8 mL and the pH 
of each sample was adjusted to 2.0±0.1 with 1 M HCl  to prevent the hydrolysis and 
polymerization of the aluminum ion.  The solutions were allowed to equilibrate at 
20±0.5 °C and 27Al NMR spectra were acquired periodically. 
The stability of the chelates towards alkaline and acidic hydrolysis was tested using 
solutions obtained by dissolving the respective crystals in water. 
 
2.4 - Animal Studies 
The in vivo experiments were carried out with well-fed male Sprague-Dawley 
rats (230 and 290 g) that had free access to a standard laboratory rat diet and drinking 
water ad libidum. For the experiments, the individual rats were anesthetized with 1.8% 
isoflurane in N2O/O2 (3:1) and cannulated in the tail vein. The animals were placed in 
prone position on a specially designed plexiglas® holder, so that the liver was in the 
sensitive volume of the NMR antenna.  The animals were positioned on the holder in 
the center of the magnet and the magnetic field was shimmed to a halfwidth of 85 Hz 
 7
(protons). Thereafter the coil was tuned to the 27Al resonance.  A water operated 
warming pad was placed on the back of the rat to maintain normal body temperature 
(measured rectally) throughout the experiment.  Subsequently, Al(NOTA) or 
Al(NODASA) solutions were infused for 72 min at rates of 3.0 and 6.3 µmol/min/kg 
body weight, respectively.  Concomitantly, the abdominal region was assessed by in 
vivo 27Al NMR spectroscopy.  At the end of the experiment, the animals were sacrificed 
by an overdose of Nembutal® and samples of blood and urine were taken.  
 
2.5 - 27Al NMR spectroscopic studies 
In vivo and in vitro 27Al NMR spectroscopy was performed on a Bruker 
BioSpec 70/20® equipped with a 7 Tesla horizontal bore magnet (27Al resonance 
frequency of 78.2 MHz).  For in vitro spectroscopy, a home-built 5-turn solenoid coil 
(10 mm inner diameter) that accomodates 0.5 mL micro tubes in vertical position with a 
snug fit was used.  The temperature was controlled with a thermostated water jacket.  
The relative concentrations of free aluminum and complexed aluminum in solution 
were quantified with 27Al NMR spectroscopy in the pulse-acquire mode whereas T1 and 
T2 relaxation were measured with a standard inversion-recovery and a spin-echo 
sequence, respectively.  In vivo 27Al NMR spectra of intact rats were obtained using a 
surface coil for signal excitation and acquisition.  A home-built single-turn coil with a 
diameter of 3.6 cm was used for the in situ assessment of Al(NOTA) whereas a 2-turn 
1.8 cm coil was employed for a more localized detection of Al(NODASA) in rat liver.  
Spectra were collected in the pulse-acquire mode in blocks of 2000 scans (6 min 10 sec) 
with a repetition time (TR) of 512 ms and 20.5 ppm spectral width.  For deeper 
penetration, the excitation pulse (50 µs) was adjusted to 180° at the coil center by 
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minimizing the signal of a reference consisting of [Al(H2O)6]
3+ (0 ppm).  Shimming 
was performed on the proton resonance of water using the 27Al coils. 27Al spectra were 
processed with a 40 Hz apodisation prior to Fourier transformation. 
 
3. Results and discussion 
3.1 - In vitro experiments 
The 27Al resonances of both chelates appear as single peaks with chemical shifts 
within the region of octahedral or pseudo-octahedral aluminum chelates.  Al(NOTA) 
has its resonance at 49 ppm [17] with a linewidth of about 60 Hz.  Al(NODASA) 
appears at 47 ppm with a halfwidth of 80 Hz (Figure 2). This result is consonant with 
the structure of the analogous Ga(NODASA), previously determined by us using X-ray 
diffraction [11].  In this work we demonstrated that the chelate is electrically neutral 
and the metal ion is fully chelated in a slightly distorted octahedral environment.  The 
β-carboxylate from the succinate pendant arm remains protonated and does not 
participate in the complexation of the metal ion.  The X-ray structure of Al(NOTA) [20] 
similarly showed that the metal ion is also chelated by the 3 nitrogen atoms of the 
triazacyclononane and by the 3 carboxylate oxygens, in an almost octahedral 
arrangement. 
  Both chelates show a linear increase of the T1 and T2 relaxation time with 
temperature (T1 and T2 relaxation times at T= 37 °C are about 20 ms).  
Al(NOTA) and Al(NODASA) were shown to be stable in a pH range between 
0.8-8.  For pH values above 9 a second peak corresponding to the formation of 
Al(OH)4
-could be detected at 80 ppm.  After 7 months in HCl (pH 0.8) the chelates 
were still almost intact (less then 1% of the Al(III) ion could be detected by 27Al NMR 
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in the form of [Al(H2O)6]3+, which demonstrates their extremely high resistance against 
acid catalyzed dissociation. 
The integration of the 27Al NMR signal of [Al(H2O)6]
3+ and Al(NODASA) at 
pH 2.1 enabled a quantitative measurement of both the free metal ([Al(III)]) and the 
bound metal ([Al(NODASA)]). The intensity of the aquaaluminum ion signal decreased 
whereas the intensity of the Al(NODASA) signal increased with time (Figure 3). After 
ca 10 months the solutions were equilibrated and the intensity of the 27Al NMR signals 
remained unchanged which allowed the estimation of the conditional stability constant 
of the complex, Kcond=[Al(NODASA)]/([Al(III)].[NODASA]). The value found was 
Kcond=6.80±0.06 M-1 to which corresponds the thermodynamic stability constant of log 
KML= 18.50±0.01.§ This value for the thermodynamic stability constant of 
Al(NODASA) indicates that the chelate might remain intact towards aluminum transfer 
to human serum transferrin (Tf) (the two macroscopic binding constants of Al-Tf are 
logK1=13.5 and logK2=12.5 at pH 7.4 [18]. The binding of Al(III) in the chelate 
prevents the metal from having a toxic effect [19].  
 
3.2 - In vivo experiments 
The infusion of Al(NOTA) in isotonic NaCl solution through tail vein injection 
in a rat started with a rate of 4 mL/h and a dead time of 7 min. In the following period a 
spectrum was acquired every 7 min.  After 15 min a 27Al NMR signal appears at 45 
ppm. Figure 4 depicts the time course of the spectra. After 72 min the infusion was 
stopped. 
Al(NODASA) in isotonic NaCl solution was also infused into the tail vein of a rat at a 
rate of 4 mL/h.  The 27Al NMR signal appeared at 46.3 ppm after 20 min p.i. (Figure 5).  
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A broadening of the signal was observed in vivo which may be explained by higher 
viscosity with concomitant increase of the rotational correlation time.  The infusion was 
stopped after 72 min. 
Atomic absorption spectroscopy for aluminum showed that the blood value was 
140 µM and the urine level was >8 mM.  In a control rat 0.3 µM of aluminum in blood 
and 1.3 µM in urine were found. 27Al NMR spectroscopy of a urine sample collected 
over a period of 24 hours only showed the characteristic signal of the chelate (Figure 2-
b), which clearly indicates that the chelate is not metabolized during the elimination 
through the kidneys. The high elimination rate via the kidneys explains the relatively 
low blood concentration. 
 
4 - Conclusions 
In vivo 27Al NMR of aluminum macrocyclic chelates was shown to be feasible.  
The low in vivo 27Al NMR signal intensity indicated low blood concentration of the 
chelates [13], which is due to the high clearance rate through the kidneys. The low 
NMR signal intensity does not allow MR- imaging within a reasonable acquisition time 
although a in vivo dynamic spectroscopic observation of the metallic chelates is 
possible.  
The short T1 time allows a fast acquisition and the relatively small half-width of 
the signal renders these aluminum chelates potential compounds for studies of 
biomedical interest.  The possibility of coupling NODASA-metal chelates to 
biomolecules through the free pendant arm [11, 21] might render possible the tunning 
of their solubility and bioselectivity thus changing their pattern of biodistribution in 
organs and tissues. 
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Footnotes 
§ We used the expression Kcond=αKML, where α−1= (1 + [H+]/K1 + [H+]2/K1K2 + ...+ 
[H+]n/K1K2...Kn); K1, K2, ...,Kn refer to the stepwise deprotonation constants of the ligand, 
determined by potentiometric titration [11]. 
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Figure 1- Chemical structures of Al(NOTA) (a) and Al(NODASA) (b). 
 
 
 
Figure 2 (a)  In vitro 27Al NMR spectrum of Al(NODASA), (H2O, 10 mM, pH = 5.5,       
T = 20 oC); the signal appears at 47 ppm with a half width of 80 Hz (200 scans).  
(b)  The in vitro 27Al NMR spectrum of Al(NODASA) in the urine of a rat collected 
over 24 hours after the chelate injection shows the same chemical shift.  
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Figure 3 – Estimation of the thermodynamic stability constant of Al(NODASA) by 
27Al NMR spectroscopy. 
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Figure 4 (a) Stack plot of the 27Al NMR spectra of the in vivo experiment with 
Al(NOTA) in a rat. For one spectrum 2000 scans were accumulated.  Prior to Fourier 
transformation the spectral data were treated with a 40 Hz Gauss filter. The linewidth 
was (unfiltered) 95 Hz.  The in vivo signal appears circa 4 ppm lower (45 ppm) than in 
vitro. As marked with an arrow the infusion was stopped and the signal intensity 
decreased.  (b)  Time course of the signal intensity (integrated area) of the spectra. The 
linear decrease of the signal intensity demonstrates a constant clearence rate. 
 
 15
 
 
Figure 5  In vivo 27Al NMR experiment with Al(NODASA) in a rat.  The spectrum was 
the sum of 3000 scans.   Also in this case the signal appears a few ppm lower than in 
vitro. 
 
